• Je něco špatně v tomto záznamu ?

Overview of novel strategies for the delivery of anthracyclines to cancer cells by liposomal and polymeric nanoformulations

M. Alavi, RS. Varma

. 2020 ; 164 (-) : 2197-2203. [pub] 20200805

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc21019729

Severe side effects and the rapid emergence of drug resistance in cancer cells are major problems in the chemotherapy utilizing anthracyclines, with a difference between cellular response at nano and micro scale levels. Understanding this situation is more complicated issue to attain efficient targeted formulations with low unexpected toxicity in patients. On nano-scale level, considering properties of nano-bio interaction in all relevant parts of the body may offer clue for suitable formulations. Four main strategies comprising PEGylation, surface charging, targeting, and stimuli responsiveness can be deployed to improve the liposomal and polymeric nanoformulations that can efficiently deliver common anthracyclines namely daunorubicin (DAU), doxorubicin (DOX), idarubicin (IDA), and epirubicin (EPI). Herein, the advances and challenges pertaining to the formulations of these anticancer drugs via liposomal and polymeric nanoformulations, are discussed.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21019729
003      
CZ-PrNML
005      
20210830101327.0
007      
ta
008      
210728s2020 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ijbiomac.2020.07.274 $2 doi
035    __
$a (PubMed)32763404
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Alavi, Mehran $u Nanobiotechnology Laboratory, Biology Department, Faculty of Science, Razi University, Kermanshah, Iran. Electronic address: mehranbio83@gmail.com
245    10
$a Overview of novel strategies for the delivery of anthracyclines to cancer cells by liposomal and polymeric nanoformulations / $c M. Alavi, RS. Varma
520    9_
$a Severe side effects and the rapid emergence of drug resistance in cancer cells are major problems in the chemotherapy utilizing anthracyclines, with a difference between cellular response at nano and micro scale levels. Understanding this situation is more complicated issue to attain efficient targeted formulations with low unexpected toxicity in patients. On nano-scale level, considering properties of nano-bio interaction in all relevant parts of the body may offer clue for suitable formulations. Four main strategies comprising PEGylation, surface charging, targeting, and stimuli responsiveness can be deployed to improve the liposomal and polymeric nanoformulations that can efficiently deliver common anthracyclines namely daunorubicin (DAU), doxorubicin (DOX), idarubicin (IDA), and epirubicin (EPI). Herein, the advances and challenges pertaining to the formulations of these anticancer drugs via liposomal and polymeric nanoformulations, are discussed.
650    _2
$a antracykliny $x aplikace a dávkování $7 D018943
650    _2
$a protinádorové látky $x aplikace a dávkování $x chemie $7 D000970
650    _2
$a farmaceutická chemie $x metody $7 D002626
650    _2
$a lidé $7 D006801
650    _2
$a liposomy $x chemie $7 D008081
650    _2
$a nanočástice $x chemie $7 D053758
650    _2
$a nádory $x farmakoterapie $7 D009369
650    _2
$a polymery $x chemie $7 D011108
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Varma, Rajender S $u Regional Centre of Advanced Technologies and Materials, Palacky University, Šlechtitelů 27, 783 71 Olomouc, Czech Republic. Electronic address: Varma.Rajender@epa.gov
773    0_
$w MED00002295 $t International journal of biological macromolecules $x 1879-0003 $g Roč. 164, č. - (2020), s. 2197-2203
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32763404 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830101327 $b ABA008
999    __
$a ok $b bmc $g 1690522 $s 1140175
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 164 $c - $d 2197-2203 $e 20200805 $i 1879-0003 $m International journal of biological macromolecules $n Int J Biol Macromol $x MED00002295
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Možnosti archivace